ArisGlobal
ArisGlobal is a private, PE-backed SaaS provider of AI-native life sciences R&D compliance software covering pharmacovigilance, regulatory affairs, quality, and medical affairs, serving 220+ global pharma, CRO, and health authority customers via its LifeSphere platform and NavaX cognitive engine.
- Company typePrivate
- Founded1987
- HeadquartersWaltham, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
What ArisGlobal does
ArisGlobal is a private, PE-backed (Nordic Capital) SaaS company that builds AI-native software for the life sciences industry, headquartered in Waltham, MA with operations in eight countries and ~1,500 professionals. Founded in 1987 with the first commercially available drug safety system, the company now offers the LifeSphere platform covering four end-to-end R&D compliance domains: pharmacovigilance (Safety), regulatory affairs, quality management, and medical affairs. Its flagship LifeSphere Safety product MultiVigilance is positioned as an industry-first end-to-end touchless case processing system, complemented by Advanced Intake, Literature Intelligence, ReporterX, Advanced Signals, Business Intelligence, Document Distribution, and Advanced Compliance Docs modules. The LifeSphere Regulatory suite spans RIM, Product Compliance, Documents, Submissions, Labeling, Analytics, Health Authority Interactions, and Regulatory Intelligence. LifeSphere Quality and LifeSphere Medical Affairs extend coverage to adjacent R&D workflows.
The company's technical differentiator is the NavaX cognitive computing engine, launched in late 2023, which delivers GenAI and Agentic AI capabilities across the entire platform. NavaX powers the NavaX Agents suite (MedDRA Coding Agent, Signals Agents, Distribution Agents, Intelligence Agents), NavaX Translation (via partnership with TransPerfect Life Sciences), and the newly launched XDI (Data Intelligence Cortex), a federated data intelligence platform unifying clinical, regulatory, PV, and quality data. The platform processes over 700,000 safety cases annually as of 2025, scaling to a projected 2.5 million by mid-2026, providing a proprietary data flywheel. Notable integrations include PubMed/Medline/Embase (literature), Spotfire (analytics), and AWS/Azure/Google/Snowflake infrastructure.
ArisGlobal operates a subscription SaaS revenue model with enterprise, quote-based pricing negotiated annually per customer. Go-to-market is direct enterprise field sales complemented by a partner ecosystem of system integrators (Accenture, Cognizant, Pinaxis, SYNRG, Navitas) and technology partners (AWS, Microsoft, Google, Snowflake). The company serves 220+ enterprise customers across global pharmaceutical companies (including 3 of the world's top 10 and named customers Roche, AstraZeneca, Boehringer Ingelheim, Astellas), CROs (EPS Corporation, Nippon Shinyaku), and government health authorities (FDA, Health Canada, NMPA). Distribution is global with offices in the United States, United Kingdom, Ireland, Germany, Croatia, Japan, China, and India; annual Breakthrough events serve as flagship GTM touchpoints for major product launches.
ArisGlobal firmographics
Firmographics- Name
- ArisGlobal
- Legal name
- ArisGlobal LLC
- Website
- https://arisglobal.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- ArisGlobal is a private, PE-backed SaaS provider of AI-native life sciences R&D compliance software covering pharmacovigilance, regulatory affairs, quality, and medical affairs, serving 220+ global pharma, CRO, and health authority customers via its LifeSphere platform and NavaX cognitive engine.
- Ownership category
- akta.pro rank
ArisGlobal industry classification
Industry- Product category
- Life Sciences R&D Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Pharmacovigilance & Drug Safety Software (HLAGAJAK)
- akta.pro secondary industries
- Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where ArisGlobal is headquartered
LocationHeadquarters
- HQ city
- Waltham
- HQ country
- United States
- HQ region
- North America
Offices9 records
Markets served
ArisGlobal business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscriptions (LifeSphere): ArisGlobal operates on a subscription/SaaS model for its LifeSphere platform, charging enterprise customers recurring fees for access to pharmacovigilance, regulatory, quality, and medical affairs software. The platform is described as a next-generation SaaS safety and regulatory platform, with cloud-based deployment and multi-tenant architecture enabling scalable compliance. Pricing is quote-based and negotiated at the enterprise level.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription — pricing not publicly disclosed |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels7 records
ArisGlobal product offering
Product offeringCore offering
ArisGlobal provides LifeSphere, an AI-first multi-tenant SaaS platform for life sciences R&D that unifies pharmacovigilance (drug safety), regulatory affairs, quality management, and medical affairs on a single cloud platform. The platform is powered by NavaX, a next-generation cognitive computing engine delivering GenAI and Agentic AI capabilities, and includes the MultiVigilance end-to-end automated touchless case processing system, AI-driven safety intake, signal detection, regulatory submissions, IDMP compliance (SPORIFY), and federated data intelligence via XDI.
Product overview
ArisGlobal offers LifeSphere, a unified platform-plus-modules architecture for life sciences R&D with integrated solutions across Safety, Regulatory, Quality, and Medical Affairs. The core LifeSphere Safety platform provides end-to-end pharmacovigilance via MultiVigilance (touchless case processing), Advanced Intake (GenAI-powered data extraction), Literature Intelligence, ReporterX, Advanced Signals, Business Intelligence, Document Distribution, and Advanced Compliance Docs. LifeSphere Regulatory spans RIM, Product Compliance, Documents, Submissions, Labeling, Analytics, Health Authority Interactions, and Regulatory Intelligence. LifeSphere Medical Affairs and LifeSphere Quality extend the platform. NavaX serves as the AI cognitive engine powering GenAI and Agentic AI capabilities across all modules, while XDI provides federated data intelligence. SPORIFY addresses IDMP compliance. All modules interoperate within the LifeSphere Unify R&D compliance platform.
Differentiator
Problem solved
Functional benefit
Brands
- LifeSphere: AI-powered SaaS platform for life sciences R&D covering Safety, Regulatory, Quality, and Medical Affairs
- NavaX
- XDI (Data Intelligence Cortex)
- SPORIFY
- MultiVigilance
- Advanced Intake
- Literature Intelligence
- ReporterX
- Advanced Signals
- Business Intelligence
- Document Distribution
- Advanced Compliance Docs
Products and services
- LifeSphere Safety Unified, next-generation SaaS safety platform providing end-to-end pharmacovigilance operations with touchless case processing, scalable compliance, and standardized global workflows. Powered by NavaX AI capabilities. For global pharma, biotech, and CRO safety teams.
- MultiVigilance End-to-end automated touchless case processing system for pharmacovigilance operations. Built to help safety teams achieve scalable, efficient, and harmonized case management while improving patient safety and compliance. Extended to medical device safety compliance.
- Advanced Intake Safety case intake automation solution leveraging cutting-edge GenAI and LLMs to streamline collection of safety data from diverse sources. Achieves up to 65% increased intake efficiency with over 90% data extraction accuracy.
- Literature Intelligence System-agnostic, GenAI-powered solution for literature intake and assessment. Automates workflows for literature screening from days to minutes, replacing manual processes with end-to-end automation for increased efficiency and data accuracy.
- ReporterX Intelligent front-end patient data collection and reporting application powered by NavaX. Secure mobile and web applications enabling stakeholders to report adverse events, medical information, and product quality complaints with AI-assisted capabilities across 32+ languages.
- Advanced Signals Next-generation signaling innovation setting a new standard in safety signaling via end-to-end signal and risk management. Includes AI-powered Signals Intelligence and Signals Agents for agentic AI-powered decision-making in signal management.
- Business Intelligence Unified hub for safety reporting, analytics, and visualization. Provides over 50 out-of-the-box industry-standard reports for regulatory, compliance, and operational use, with intelligent analytics powered by Spotfire.
- Document Distribution Single automated platform for oversight and distribution of safety content. Enables real-time distribution of safety reports to key stakeholder groups with audit readiness and customizable dashboards.
- Advanced Compliance Docs Unified platform for managing safety documents and data powered by NavaX. Centralized solution for creating, storing, and managing medical writing, PSMF, PVAs and other critical safety documentation with up to 70% faster medical authoring.
- LifeSphere Regulatory Comprehensive regulatory affairs platform transforming operations with GenAI and Agentic AI capabilities powered by NavaX. Seamlessly brings together data, content, and processes across end-to-end regulatory lifecycle.
- LifeSphere Medical Affairs Medical affairs platform enabling seamless information flow and automation across Medical Affairs, Safety, and Product Complaints. Natively integrated with Safety and Quality systems via LifeSphere Unify.
- LifeSphere Quality Complete solution for quality management and documentation needs of life sciences companies across R&D, Clinical, Regulatory, Pharmacovigilance, and Manufacturing with industry-specific requirements.
- NavaX Next-gen cognitive computing engine accelerating application of artificial intelligence across LifeSphere platforms. Powers GenAI and Agentic AI capabilities including automation, translation, signal detection, and intelligent agents for life sciences R&D.
- NavaX Agents Suite of AI-powered autonomous agents operating within LifeSphere Unify platform. Includes MedDRA Coding Agent (Frost & Sullivan 2025 New Product Innovation Award winner, up to 80% efficiency gains), Signals Agents, Distribution Agents, and Intelligence Agents for regulatory and safety operations.
- NavaX Translation Translation solution developed through partnership with TransPerfect Life Sciences, embedding certified pharma-grade translation directly into LifeSphere Safety workflows. Reduces translation time from approximately 5 hours to under 1 minute per case, with over 95% data accuracy.
- XDI (Data Intelligence Cortex) Federated data intelligence solution transforming regulated life sciences data into explainable, decision-grade intelligence across pharmacovigilance, regulatory, medical affairs, quality, and benefit-risk functions without requiring data consolidation.
- SPORIFY AI-powered solution for SPOR and ISO IDMP compliance, helping track global regulatory changes and accelerate compliance with pharmaceutical data standards.
Quantifiable outcome
- Up to 65% increased efficiency via safety case intake automation
- +14 more outcomes
Companies that use ArisGlobal
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
ArisGlobal technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability12 records
Feature10 records
ArisGlobal partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, major and minor.
- TransPerfect Life SciencescoreStrategic partnership to embed certified, pharma-grade translation directly into LifeSphere Safety workflows via NavaX Translation. The solution integrates AI-powered language detection and expert human linguists to reduce case translation time from approximately 5 hours to under 1 minute. NavaX Translation leverages TransPerfect's certified translation capabilities to enable compliant multilingual pharmacovigilance operations. The platform currently processes over 1 million safety cases with projections to scale to 2.5 million cases by mid-2026.
- CelegencecoreStrategic partnership to empower life sciences regulatory transformation. Celegence specializes in regulatory compliance and submission solutions, and the partnership aims to enhance ArisGlobal's regulatory offerings and enable faster compliance for shared customers.
- SiterocoreExpanded strategic partnership to enable best-in-class capabilities across the complete drug development technology platform. The partnership integrates ArisGlobal's safety and regulatory solutions with Sitero's clinical trial technology suite for end-to-end drug development coverage.
- AccenturecoreSystem integrator partner within the ArisGlobal Partner Network. Accenture provides consulting and implementation services to help deploy and customize ArisGlobal's LifeSphere platform for enterprise customers across the life sciences sector.
- CognizantmajorSystem integrator and business process partner within the ArisGlobal Partner Network. Cognizant provides implementation and consulting services for ArisGlobal platform deployments.
- PinaxisminorSystem integrator partner within the ArisGlobal Partner Network providing implementation services for ArisGlobal solutions.
- SYNRGminorSystem integrator and business process partner within the ArisGlobal Partner Network.
- Navitas (Sitero)minorSystem integrator partner within the ArisGlobal Partner Network (listed alongside Sitero branding).
- AWS (Amazon Web Services)coreTechnology partner providing cloud infrastructure for ArisGlobal's SaaS platform. AWS enables the scalable, secure cloud deployment of LifeSphere across global customers.
- MicrosoftcoreTechnology partner providing cloud infrastructure (Azure) and potentially AI/ML capabilities supporting ArisGlobal's platform.
- GooglemajorTechnology partner within the ArisGlobal Partner Network, providing cloud infrastructure and potentially AI/ML capabilities.
- SnowflakemajorTechnology partner providing data cloud infrastructure enabling ArisGlobal's cross-domain data integration and analytics capabilities.
Scale indicators9 records
Recent moves6 records
Expansion highlights7 records
ArisGlobal competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva's Vault Safety, Vault RIM, Vault Quality, and Vault Submissions directly compete with ArisGlobal's LifeSphere platform across pharmacovigilance, regulatory information management, and quality. Veeva is the most entrenched life sciences SaaS platform with deeper CRM and commercial footprint. ArisGlobal's COO previously led Veeva's Vault Safety practice.
- Instem: Instem provides software and services for safety assessment, regulatory submissions (Submit suite), and pre-clinical informatics. Directly comparable to ArisGlobal's safety/regulatory modules, particularly for CRO and mid-size pharma segments.
- Honeywell (Sparta Systems TrackWise): Honeywell's TrackWise enterprise QMS platform competes directly with ArisGlobal's LifeSphere Quality and Quality Documents modules in regulated life sciences. Broader Honeywell portfolio includes process automation for manufacturing quality.
- Ennov: Ennov provides a unified SaaS platform covering Pharmacovigilance, Regulatory (RIM), and Quality Management for life sciences, closely mirroring ArisGlobal's LifeSphere Safety/Regulatory/Quality portfolio. Mid-size player specializing in the same regulatory and compliance workflows for mid-market pharma.
Emerging players
- Clario: Clario (formerly Bioclinica, where ArisGlobal CEO Aman Wasan previously led Safety and Regulatory Services) provides clinical and safety technology solutions for clinical trials. Partial overlap with ArisGlobal's safety intake and clinical trial informatics via Sitero partnership.
- MaxisIT: MaxisIT provides AI-enabled clinical trial and safety technology (EDC, RTSM, safety) targeting mid-size pharma and CROs. Comparable scope to ArisGlobal's clinical informatics modules and pharmacovigilance offerings for similar customer profiles.
Broad incumbents
- IQVIA: IQVIA combines technology (e.g., EDC, RTSM, safety) with CRO and real-world evidence services. Its technology arm competes for life sciences compliance workflows, while its broader services portfolio makes it a one-stop alternative to ArisGlobal's pure-software focus.
- Parexel International: Parexel is a major CRO with proprietary technology platforms (e.g., PeriNurse, eProm) supporting pharmacovigilance and clinical operations. Competes with ArisGlobal's CRO-targeted MultiVigilance offering through bundled services rather than standalone SaaS.
- Dassault Systèmes (Medidata): Medidata (a Dassault Systèmes brand) offers the Rave Clinical Cloud (EDC/CTMS/eCOA), BIOVIA for scientific informatics, and broader 3DEXPERIENCE platform for life sciences. Strong overlap with ArisGlobal's clinical trial informatics and scientific data management ambitions, especially relevant given the Sitero partnership.
- Oracle Health Sciences: Oracle's Clinical One platform, Argus Safety (pharmacovigilance), and InForm compete across safety and clinical trials. As a large incumbent ERP/cloud vendor, Oracle offers life sciences capabilities as part of a broader technology portfolio rather than specializing in PV/RIM the way ArisGlobal does.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights8 records
Customer concentration
ArisGlobal social profiles
Digital presenceArisGlobal compliance and trust
Trust signalCompliance3 records
ArisGlobal financial estimates
Financial estimateRevenue estimate
Valuation estimate
ArisGlobal leadership team
Management profileNumber of profiles
Profiles9 records
ArisGlobal subsidiaries and ownership
Company hierarchySubsidiaries1 record
ArisGlobal funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ArisGlobal M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ArisGlobal
What does ArisGlobal do?
ArisGlobal provides LifeSphere, an AI-first multi-tenant SaaS platform for life sciences R&D that unifies pharmacovigilance (drug safety), regulatory affairs, quality management, and medical affairs on a single cloud platform. The platform is powered by NavaX, a next-generation cognitive computing engine delivering GenAI and Agentic AI capabilities, and includes the MultiVigilance end-to-end automated touchless case processing system, AI-driven safety intake, signal detection, regulatory submissions, IDMP compliance (SPORIFY), and federated data intelligence via XDI.
Is ArisGlobal a public or private company?
ArisGlobal is a private company. It is classified as private equity controlled and is currently operating.
When was ArisGlobal founded?
ArisGlobal was founded in 1987. It employs 1,001 to 5,000 people.
Where is ArisGlobal based?
ArisGlobal is headquartered in Waltham, United States, in the North America region.
How does ArisGlobal make money?
One revenue line is on record: saaS Platform Subscriptions (LifeSphere).
Who are ArisGlobal's main competitors?
Direct peers on record are Veeva Systems, Instem, Honeywell (Sparta Systems TrackWise) and Ennov. Emerging players are Clario and MaxisIT. Broad incumbents are IQVIA, Parexel International, Dassault Systèmes (Medidata) and Oracle Health Sciences.
Does ArisGlobal have an API?
No public API is recorded for ArisGlobal.
What industry is ArisGlobal in?
ArisGlobal's product category is Life Sciences R&D Software. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLAGAJAL, Regulatory Information Management (RIM) & Submission Publishing Software. Its NAICS code is 5132 and its SIC code is 7372.